adenosine A2A agonists (Inspyr Therapeutics)

N/A

Report date: 2025/03/14 16:33:30
NME

Base Information

Drug Nameadenosine A2A agonists (Inspyr Therapeutics)
Drug Alias Nameadenosine A2A agonists (Lewis & Clark Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsPainInflammationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLewis & Clark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInspyr Therapeutics
Inactive CompaniesLewis & Clark Pharmaceuticals Inc
Active IndicationsAtherosclerosisArthritis
Inactive IndicationsPainInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A